ProCE Banner Events

IMFINZI (durvalumab) + Gem/Cis: The First FDA Approved First-Line Treatment for Locally Advanced or Metastatic Biliary Tract Cancers

Explore a First-Line Treatment for Locally Advanced or Metastatic Biliary Tract Cancers

Key Takeaways:

  • Diagnosis and management of biliary tract cancers, TOPAZ-1 trial results, and important safety information.

This event has expired. No longer available for credits.

Time and location

Wednesday, October 30, 2024

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Faculty
Sofya Pintova, MD

Assistant Professor
Ichan School of Medicine at Mount Sinai
New York, New York

Sponsored By

AstraZeneca

ProCE Banner